Harris Associates’s Pfizer PFE Stock Holding History

Harris Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,039	Closed	-$319K	–	131
2015 Q2	$319K	Sell	10,039 -11,268	-53%	-$367K	﹤0.01%	136
2015 Q1	$703K	Sell	21,307 -22,136	-51%	-$704K	﹤0.01%	143
2014 Q4	$1.28M	Hold	43,443	–	–	﹤0.01%	144
2014 Q3	$1.22M	Hold	43,443	–	–	﹤0.01%	143
2014 Q2	$1.22M	Sell	43,443 -421	-1%	-$12K	﹤0.01%	143
2014 Q1	$1.34M	Buy	43,864 +421	+1%	+$12.6K	﹤0.01%	142
2013 Q4	$1.26M	Sell	43,443 -1,054	-2%	-$30.7K	﹤0.01%	150
2013 Q3	$1.21M	Sell	44,497 -843	-2%	-$22.9K	﹤0.01%	146
2013 Q2	$1.21M	Buy	+45,340	New	+$1.25M	﹤0.01%	153

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Harris Associates's PFE Position: Q3 2015 in Review

Harris Associates sold out of Pfizer (PFE) in Q3 2015, closing a stake of 10,039 shares — an estimated $319K sold.

Harris Associates first reported a position in PFE in Q2 2013 and held it in 9 quarters. The position peaked at $1.34M in Q1 2014. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Harris Associates reported no remaining Pfizer position as of Q3 2015 after selling out during the quarter.
Harris Associates sold 10,039 Pfizer shares in Q3 2015, an estimated $319K.
Harris Associates first reported a position in Pfizer in Q2 2013 and held it in 9 quarters.
Harris Associates's Pfizer position peaked at $1.34M in Q1 2014.
1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Harris Associates's 13F filing for Q3 2015, filed 13 Nov 2015.